ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 8th, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 8th, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 21, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Puja Leekha (the “Executive”).
ORTHOFIX MEDICAL INC. AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN Stock Unit Grant Agreement COVER SHEETStock Unit Grant Agreement • November 8th, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionOrthofix Medical Inc., a Delaware corporation (the “Company”), hereby grants to the Award Recipient named below, on the Grant Date set forth below, the specified number of Stock Units relating to shares of the Company’s common stock, par value $0.10 per share (the “Stock”) under the Plan, subject to the vesting schedule and terms and conditions set forth below (the “Award”). Additional terms and conditions of the Stock Units are set forth on this cover sheet, in the attached Stock Unit Grant Agreement (together, the “Agreement”), and in the Company’s Amended and Restated 2012 Long-Term Incentive Plan (as amended from time to time, the “Plan”). Capitalized terms used and not otherwise defined herein shall have the meanings attributed thereto in the Plan.
ORTHOFIX MEDICAL INC. SEVERANCE AGREEMENTSeverance Agreement • November 8th, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 8th, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of October 2, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Geoffrey C. Gillespie (the “Executive”).